AUROVISC- hypromellose ophthalmic solution 2% w/v solution 
Aurolab

----------

ACTIVE INGREDIENT

Hypromellose USP 2% w/v

INACTIVE INGREDIENT

  1. Acetic acid 1%
  2. Calcium chloride
  3. Citric acid 0.1465%
  4. Magnesium Chloride
  5. Sodium chloride
  6. Sodium acetate,
  7. Sodium Citrate
  8. Potassium chloride
  9. Purified water.

USE

For use as a lubricant to prevent further irritation or to relieve dryness of the eye

QUESTIONS

Call. 1-800-103-7321,

E-mail : info@aurolab.com
Web : www.aurolab.com

KEEP OUT OF REACH OF CHILDREN

If swallowed get medical help or contact a Poison Control Center right away.

STOP USE

  1. Transient blurring of vision
  2. Ocular discomfort or irritation
  3. Matting or Stickness of eyelashes
  4. Photophobia
  5. Hypersensitivity or edema of the eyelids

DO NOT USE

  1. If the solution becomes dark brown or any floating particles are observed.
  2. If you are sensitive to any ingredient in this product

WARNINGS

For External use only

INDIACATIONS AND USAGE

Do not use if package is damaged
Discard after a single use
Do not freeze
Do not resterilize

Purpose

Lubricant

Dose

Instill 1 or 2 drops in the affected eyes as needed

PACKAGE CARTON

HPMC

AUROVISC 
hypromellose ophthalmic solution 2% w/v solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:16030-301
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2) (HYPROMELLOSE 2208 (15000 MPA.S) - UNII:Z78RG6M2N2) HYPROMELLOSE 2208 (15000 MPA.S)20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM ACETATE (UNII: 4550K0SC9B)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
ACETIC ACID (UNII: Q40Q9N063P)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
CITRIC ACID ACETATE (UNII: DSO12WL7AU)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:16030-301-022 mL in 1 SYRINGE, GLASS; Type 1: Convenience Kit of Co-Package09/26/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01809/26/2022
Labeler - Aurolab (677319965)
Establishment
NameAddressID/FEIBusiness Operations
Aurolab DBA Aurolab Trust677319965manufacture(16030-301)

Revised: 1/2026
Document Id: 47edd91f-7908-3a97-e063-6294a90ad9df
Set id: e9100312-b105-50a6-e053-2a95a90ac31f
Version: 5
Effective Time: 20260108
 
Aurolab